Skip to content
DataLookout
Menu

NCT05058508

LCI-PED-NOS-EXER-001: Exercise in Pediatric Oncology Patients

StatusActive, Not Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 24 versions: 20 with changes below, 4 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 13 words Show 7 more changesShow less
    • Primary endpoints: details revised at 2 of 2 entries
    • Enrollment closed, study ongoing
    • Final enrollment: 10 participants (planned 60)
    • Primary and study completion dates: Nov 2027 to Nov 30, 2027
    • Interventions: "Just Move" Exercise (Other), Standard of Care Exercise (Other) to "Just Move" Exercise (Other), Standard of Care Exercise (Other)
    • Secondary endpoints: details revised at 4 of 4 entries
    • Site details revised
  2. Notable Eligibility criteria shortened, about 1 wordv22
  3. Notable Eligibility criteria expanded, about 111 words
    • Site contact updated
    v21
  4. Notable Primary and study completion dates: Oct 1, 2025 to Nov 2027
    • Eligibility criteria shortened, about 9 words
    • Site contact updated
    v20
  5. Minor Secondary endpoints revised (4)v18
Show 14 earlier versionsHide 14 earlier versions
  1. Minor Secondary endpoints expanded, about 23 wordsv17
  2. Minor Start date changed from estimate of Apr 2024 to Mar 11, 2024v16
  3. Notable Start date: Feb 2024 to Apr 2024v15
  4. Notable Primary and study completion dates: Mar 1, 2024 to Oct 1, 2025
    • Start date: Dec 2023 to Feb 2024
    v14
  5. Notable Start date: Nov 1, 2023 to Dec 2023
    • Site contact updated
    • Collaborators expanded, about 5 words
    v13
  6. Notable Start date: Oct 1, 2023 to Nov 1, 2023v12
  7. Notable Start date: Jun 1, 2023 to Oct 1, 2023v11
  8. Notable Start date: Mar 2, 2023 to Jun 1, 2023v10
  9. Notable Start date: Mar 2, 2022 to Mar 2, 2023v9
  10. Notable Lead sponsor: Jamie Mochel to Wake Forest University Health Sciencesv7
  11. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date: Apr 1, 2022 to Mar 2, 2022
    v5
  12. Notable Start date: Jan 31, 2022 to Apr 1, 2022v4
  13. Notable Start date: Dec 1, 2021 to Jan 31, 2022v3
  14. Notable Start date: Oct 1, 2021 to Dec 1, 2021v2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Potential benefit of increasing/maintaining physical functioning in pediatric subjects undergoing chemotherapy and childhood cancer treatment
Timeframe: 18 month period

Secondary (4)

Adverse Event Rate
Quality of Life measured by the PedsQL Cancer Module
Subject adherence to exercise regimen
Adverse Events Related to Exercise Program

Arms and interventions

EXERExperimental

"Just Move" exercises

SOC EXERExperimental

Standard of Care Exercise

Other: "Just Move" Exercise, Standard of Care Exercise

Sites

1 site in 1 country

  • Levine Children's HospitalCharlotte, North Carolina, United States